Compare · MMED vs RMD
MMED vs RMD
Side-by-side comparison of MiniMed Group Inc. (MMED) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MMED and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $32.03B, about 8.6x MMED ($3.71B).
- Over the past year, MMED is down 28.0% and RMD is down 6.1% - RMD leads by 21.9 points.
- Both names hit the wire about 2 times in the past 4 weeks.
- RMD has more recent analyst coverage (25 ratings vs 11 for MMED).
- Company
- MiniMed Group Inc.
- ResMed Inc.
- Price
- -
- -
- Market cap
- $3.71B
- $32.03B
- 1M return
- -17.86%
- -2.86%
- 1Y return
- -27.98%
- -6.09%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2026
- News (4w)
- 2
- 2
- Recent ratings
- 11
- 25
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Latest MMED
- SEC Form 10-Q filed by MiniMed Group Inc.
- MiniMed to announce financial results for its fourth quarter and full fiscal year 2026
- BTIG Research initiated coverage on MiniMed with a new price target
- Deutsche Bank initiated coverage on MiniMed with a new price target
- BofA Securities initiated coverage on MiniMed with a new price target
- Piper Sandler initiated coverage on MiniMed with a new price target
- Mizuho initiated coverage on MiniMed with a new price target
- Morgan Stanley initiated coverage on MiniMed with a new price target
- Citigroup initiated coverage on MiniMed with a new price target
- Evercore ISI initiated coverage on MiniMed with a new price target
Latest RMD
- Analyst initiated coverage on ResMed
- SEC Form 4 filed by Farrell Michael J.
- SEC Form 4 filed by Sandercock Brett
- SEC Form 4 filed by Farrell Peter C
- SEC Form 144 filed by ResMed Inc.
- Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by ResMed Inc.
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,252,902 worth of ResMed Common Stock (4,991 units at $251.03) (SEC Form 4)
- Director Farrell Peter C sold $520,440 worth of ResMed Common Stock (2,000 units at $260.22), decreasing direct ownership by 3% to 62,773 units (SEC Form 4)
- SEC Form 144 filed by ResMed Inc.